![]() |
|
Featured CompaniesSuining Yinfa DAR Industrial Co., Ltd. (DAR Industrial) is a subsidiary of China Health Resource,Inc.! Suining Yinfa DAR Industrial Co., Ltd. (DAR Industrial) is a subsidiary of China Health Resource,Inc. (collectively refer to as CHRI). The company runs the production, further processing, sales of one of the major traditional Chinese herbs, Dahurian Angelica Root (DAR) that is widely used in medicine to fight against pain, high blood pressure, cancer etc., as well as other industries like cosmetic, chemistry. We participated the making of national standard of DAR, and the GAP (Good Agriculture Product) which has just been approved by the State Food and Drug Administration and became the sole standard of DAR. CHRI is located in Sichuan province, where grows the finest DAR and its total output accounts for over 70% of the country's. About Suining Yinfa DAR Industrial Co., Ltd. The Product
The Root Dahurian Angelica Root (DAR), the root of an herb, Dahurian Angelica, which is widely used in China, and considered to be an important ingredient Chinese traditional medicine. How It's Being UsedThe root together with other Chinese herb can be boiled with water to drink to serve as a cure or further process into abstract to become an ingredient of a pill. How CHRI Has The Best Quality CHRI participated the making of DAR standard, Good Agriculture Product (GAP), a method used in European Union for all its agricultural products and was recently introduced into China. This allows our DAR growing to be a leader in the business. CHRI has GAP certification. Distinguish Between GAP DAR and Normal DAR
What's more, Suining City , where CHRI's DAR is grown has the good soil for DAR. The soil is nutritious, rich in micronutrients especially Potassium and Phosphorus. All The Different Applications That The Root Has... To cure pain, swelling and pustule, to reduce itching. It has an aroma to awake the brain. What Revenues Could Grow To... By the end of the 3 rd year, the revenue will $130,000,000. Net profit will be $22,000,000 Acquisitions CHRI signed merger letter of intent (LOI) with Sichuan Zhufeng Medicine Co. (a company with GMP certified factory). It will give a boost to the accomplishment of the industrial chain integration plan of CHRI by forming a GMP (Good Manufacture Practice) pharmacy which is one of the three parts of the industrial chain, for the merged Zhufeng will become the production base of CHRI for DAR processed products. Zhufeng Medicine Co. is a pharmacy with the primary business of 20 types of biological medicines production. It has a factory consistent with GMP criterion. Its core product, Saffron Oil, is the first class medicine in China . The output and revenue in 2006 was $ 8 million. Growth Strategies
By combining 1, 2 and 3, CHRI can become very competitive in the industry, gain high added value of DAR and take up a large percentage of market share. |
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| © 2008 MaverickStocks.com All Rights Reserved. Disclaimer & Disclosure | Site design by AlphaTrade.com |